Comparison of Second-Phase Insulin Secretion Derived from Standard and Modified Low-Dose Graded Glucose Infusion Tests

Jiunn Diann Lin, Chung Ze Wu, Wen Hao Tang, Feng Chih Kuo, Dee Pei, Yao Jen Liang, Yen Lin Chen

Research output: Contribution to journalArticle

Abstract

Objectives: Insulin secretion has 2 phases, first-phase and second-phase insulin secretion (SPIS). The purpose of our study was to validate the SPIS derived from the modified low-dose graded glucose infusion test (MLDGGI) by using the standard SPIS derived from the low-dose graded glucose infusion test (LDGGI). Methods: Fourteen participants were enrolled. The participants underwent the LDGGI for 200 minutes and MLDGGI for 60 minutes. The LDGGI was administered using the standard Polonsky method, which entails 5 40-minute stages of glucose infusion (1, 4, 8, 6 and 24 mg/kg/min). The slopes of the insulin levels vs. the glucose levels obtained during the test were regarded as SPIS (SPIS-I). Furthermore, deconvolution was performed, and slopes of the insulin secretion rate (ISR) against glucose levels during the test (SPIS-D) were obtained and regarded as the gold standard SPIS. The MLDGGI was administered with 3 20-minute stages of glucose infusion (2, 8 and 24 mg/kg/min) for 20 minutes each. The slopes of the insulin levels vs. the glucose levels obtained during the test were regarded as SPIS (MSPIS-I). In addition, deconvolution was performed, and the slopes of the ISR against glucose levels during the test (MSPIS-D) were obtained. Results: Significant correlations were observed between SPIS-I and SPIS-D (r=0.843; p

Original languageEnglish
Pages (from-to)529-534
JournalCanadian Journal of Diabetes
Volume40
Issue number6
DOIs
Publication statusPublished - Dec 1 2016

Fingerprint

Insulin
Glucose

Keywords

  • Low-dose graded glucose infusion test
  • Modified low-dose graded glucose infusion test
  • Second-phase insulin secretion

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Comparison of Second-Phase Insulin Secretion Derived from Standard and Modified Low-Dose Graded Glucose Infusion Tests. / Lin, Jiunn Diann; Wu, Chung Ze; Tang, Wen Hao; Kuo, Feng Chih; Pei, Dee; Liang, Yao Jen; Chen, Yen Lin.

In: Canadian Journal of Diabetes, Vol. 40, No. 6, 01.12.2016, p. 529-534.

Research output: Contribution to journalArticle

Lin, Jiunn Diann ; Wu, Chung Ze ; Tang, Wen Hao ; Kuo, Feng Chih ; Pei, Dee ; Liang, Yao Jen ; Chen, Yen Lin. / Comparison of Second-Phase Insulin Secretion Derived from Standard and Modified Low-Dose Graded Glucose Infusion Tests. In: Canadian Journal of Diabetes. 2016 ; Vol. 40, No. 6. pp. 529-534.
@article{ee09bce3513f450688809e00ad310ca6,
title = "Comparison of Second-Phase Insulin Secretion Derived from Standard and Modified Low-Dose Graded Glucose Infusion Tests",
abstract = "Objectives: Insulin secretion has 2 phases, first-phase and second-phase insulin secretion (SPIS). The purpose of our study was to validate the SPIS derived from the modified low-dose graded glucose infusion test (MLDGGI) by using the standard SPIS derived from the low-dose graded glucose infusion test (LDGGI). Methods: Fourteen participants were enrolled. The participants underwent the LDGGI for 200 minutes and MLDGGI for 60 minutes. The LDGGI was administered using the standard Polonsky method, which entails 5 40-minute stages of glucose infusion (1, 4, 8, 6 and 24 mg/kg/min). The slopes of the insulin levels vs. the glucose levels obtained during the test were regarded as SPIS (SPIS-I). Furthermore, deconvolution was performed, and slopes of the insulin secretion rate (ISR) against glucose levels during the test (SPIS-D) were obtained and regarded as the gold standard SPIS. The MLDGGI was administered with 3 20-minute stages of glucose infusion (2, 8 and 24 mg/kg/min) for 20 minutes each. The slopes of the insulin levels vs. the glucose levels obtained during the test were regarded as SPIS (MSPIS-I). In addition, deconvolution was performed, and the slopes of the ISR against glucose levels during the test (MSPIS-D) were obtained. Results: Significant correlations were observed between SPIS-I and SPIS-D (r=0.843; p",
keywords = "Low-dose graded glucose infusion test, Modified low-dose graded glucose infusion test, Second-phase insulin secretion",
author = "Lin, {Jiunn Diann} and Wu, {Chung Ze} and Tang, {Wen Hao} and Kuo, {Feng Chih} and Dee Pei and Liang, {Yao Jen} and Chen, {Yen Lin}",
year = "2016",
month = "12",
day = "1",
doi = "10.1016/j.jcjd.2016.03.007",
language = "English",
volume = "40",
pages = "529--534",
journal = "Canadian Journal of Diabetes",
issn = "1499-2671",
publisher = "Canadian Diabetes Association",
number = "6",

}

TY - JOUR

T1 - Comparison of Second-Phase Insulin Secretion Derived from Standard and Modified Low-Dose Graded Glucose Infusion Tests

AU - Lin, Jiunn Diann

AU - Wu, Chung Ze

AU - Tang, Wen Hao

AU - Kuo, Feng Chih

AU - Pei, Dee

AU - Liang, Yao Jen

AU - Chen, Yen Lin

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Objectives: Insulin secretion has 2 phases, first-phase and second-phase insulin secretion (SPIS). The purpose of our study was to validate the SPIS derived from the modified low-dose graded glucose infusion test (MLDGGI) by using the standard SPIS derived from the low-dose graded glucose infusion test (LDGGI). Methods: Fourteen participants were enrolled. The participants underwent the LDGGI for 200 minutes and MLDGGI for 60 minutes. The LDGGI was administered using the standard Polonsky method, which entails 5 40-minute stages of glucose infusion (1, 4, 8, 6 and 24 mg/kg/min). The slopes of the insulin levels vs. the glucose levels obtained during the test were regarded as SPIS (SPIS-I). Furthermore, deconvolution was performed, and slopes of the insulin secretion rate (ISR) against glucose levels during the test (SPIS-D) were obtained and regarded as the gold standard SPIS. The MLDGGI was administered with 3 20-minute stages of glucose infusion (2, 8 and 24 mg/kg/min) for 20 minutes each. The slopes of the insulin levels vs. the glucose levels obtained during the test were regarded as SPIS (MSPIS-I). In addition, deconvolution was performed, and the slopes of the ISR against glucose levels during the test (MSPIS-D) were obtained. Results: Significant correlations were observed between SPIS-I and SPIS-D (r=0.843; p

AB - Objectives: Insulin secretion has 2 phases, first-phase and second-phase insulin secretion (SPIS). The purpose of our study was to validate the SPIS derived from the modified low-dose graded glucose infusion test (MLDGGI) by using the standard SPIS derived from the low-dose graded glucose infusion test (LDGGI). Methods: Fourteen participants were enrolled. The participants underwent the LDGGI for 200 minutes and MLDGGI for 60 minutes. The LDGGI was administered using the standard Polonsky method, which entails 5 40-minute stages of glucose infusion (1, 4, 8, 6 and 24 mg/kg/min). The slopes of the insulin levels vs. the glucose levels obtained during the test were regarded as SPIS (SPIS-I). Furthermore, deconvolution was performed, and slopes of the insulin secretion rate (ISR) against glucose levels during the test (SPIS-D) were obtained and regarded as the gold standard SPIS. The MLDGGI was administered with 3 20-minute stages of glucose infusion (2, 8 and 24 mg/kg/min) for 20 minutes each. The slopes of the insulin levels vs. the glucose levels obtained during the test were regarded as SPIS (MSPIS-I). In addition, deconvolution was performed, and the slopes of the ISR against glucose levels during the test (MSPIS-D) were obtained. Results: Significant correlations were observed between SPIS-I and SPIS-D (r=0.843; p

KW - Low-dose graded glucose infusion test

KW - Modified low-dose graded glucose infusion test

KW - Second-phase insulin secretion

UR - http://www.scopus.com/inward/record.url?scp=84970003936&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84970003936&partnerID=8YFLogxK

U2 - 10.1016/j.jcjd.2016.03.007

DO - 10.1016/j.jcjd.2016.03.007

M3 - Article

C2 - 27247269

AN - SCOPUS:84970003936

VL - 40

SP - 529

EP - 534

JO - Canadian Journal of Diabetes

JF - Canadian Journal of Diabetes

SN - 1499-2671

IS - 6

ER -